Patents by Inventor Pei-Chin Cheng

Pei-Chin Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV protease inhibitors
    Patent number: 8389560
    Abstract: This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: March 5, 2013
    Assignee: TaiGen Biotechnology Co., Ltd.
    Inventors: Chen-Fu Liu, Kuang-Yuan Lee, Pei-Chin Cheng, Yo-Chin Liu, Pin Lo, Kuo-Feng Tseng, Chih-Ming Chen, Chi-Hsin Richard King, Chu-Chung Lin
  • HCV PROTEASE INHIBITORS
    Publication number: 20110065737
    Abstract: This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Application
    Filed: September 15, 2009
    Publication date: March 17, 2011
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chen-Fu Liu, Kuang-Yuan Lee, Pei-Chin Cheng, Yo-Chin Liu, Pin Lo, Kuo-Feng Tseng, Chih-Ming Chen, Chi-Hsin Richard King, Chu-Chung Lin
  • Aminoquinoline compounds
    Patent number: 7378524
    Abstract: This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: May 27, 2008
    Assignee: Taigen Biotechnology Co., Ltd.
    Inventors: Chu-Chung Lin, Jen-Fuh Liu, Chih-Wei Chang, Shu-Jen Chen, Yibin Xiang, Pei-Chin Cheng, Jiing-Jyh Jan
  • HCV PROTEASE INHIBITORS
    Publication number: 20080108632
    Abstract: This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 8, 2008
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chu-chung Lin, Pei-chin Cheng, Yo-chin Liu, Chen-fu Liu, Chi-Hsin Richard King
  • Aminoquinoline compounds
    Patent number: 7183413
    Abstract: This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: February 27, 2007
    Assignee: Taigen Biotechnology
    Inventors: Chu-Chung Lin, Jen-Fuh Liu, Chih-Wei Chang, Shu-Jen Chen, Yibin Xiang, Pei-Chin Cheng, Jiing-Jyh Jan
  • Aminoquinoline compounds
    Publication number: 20050070573
    Abstract: This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
    Type: Application
    Filed: September 29, 2004
    Publication date: March 31, 2005
    Inventors: Chu-Chung Lin, Jen-Fuh Liu, Chih-Wei Chang, Shu-Jen Chen, Yibin Xiang, Pei-Chin Cheng, Jiing-Jyh Jan
  • Aminoquinoline compounds
    Publication number: 20040209902
    Abstract: This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
    Type: Application
    Filed: April 6, 2004
    Publication date: October 21, 2004
    Inventors: Chu-Chung Lin, Jen-Fuh Liu, Chih-Wei Chang, Shu-Jen Chen, Yibin Xiang, Pei-Chin Cheng, Jiing-Jyh Jan